Under construction – not a live service
Sign in
Taking peopleNo phase

Comparative Efficacy of Magnesium Supplement and Melatonin Congener in Young Adults With Primary Insomnia

Key facts

Who runs it
CMH Kharian Medical College
Where
Pakistan1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
60 people, planned
Started
5 May 2025
Planned end
30 Oct 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Magnesium glycinate
  • Melatonin
Record updated
30 May 2025

Who can take part

Age
18 years to 40 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Age 18-40 years
  • Gender: Male and Females (Non-pregnant \& Non lactating)
  • Diagnosed cases of primary insomnia according to following criteria:; Difficulty falling asleep, staying asleep or nonrestorative sleep; This difficulty is present despite adequate opportunity \& circumstance to sleep; This impairment in sleep is associated with daytime impairment or distress; This sleep difficulty occurs at least 3 times per week and has been a problem for at least 1 month

Who cannot take part

  • Any psychiatric illness
  • Insomnia due to a known underlying cause
  • Active use of sedative hypnotics

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 40 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Sleep is essential for our overall health and well-being, much like food and water. It plays a vital role in numerous bodily functions. Many studies have been conducted to determine the efficacy of melatonin congeners and Mg supplements in patients with insomnia separately. This study aims to compare the efficacy of melatonin and magnesium supplements in young adults with primary insomnia. Most insomnia studies focus on older adults or individuals with comorbidities. Targeting otherwise healthy young adults brings age-specific relevance and novel insight.

The 2 groups in the trial

  • Group ATreatment being tested

    Group A will receive magnesium supplements for 4 weeks (Oral, Tablet, Dose 500mg/day at night)

    Treatment: Magnesium glycinate

  • Group BExisting treatment, for comparison

    Group B will receive melatonin congener for 4 weeks (Oral, Tablet, Dose 10mg/day at night)

    Treatment: Melatonin

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Fit questions
Built from NCT06996171, who can take part
Record updated
30 May 2025